Review



lif recombinant human protein (hlif  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher lif recombinant human protein (hlif
    Lif Recombinant Human Protein (Hlif, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lif+recombinant+human+protein+(hlif/pm35772103-23-44-49
    Average 90 stars, based on 1 article reviews
    lif recombinant human protein (hlif - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: A novel rhamnoside derivative PL402 up-regulates matrix metalloproteinase 3/9 to promote Aβ degradation and alleviates Alzheimer’s-like pathology
    Article Snippet: .. Human iPSC-derived neural stem cells (hNSCs) were maintained as adherent culture in 50% DMEM-F12 and 50% Neurobasal®-A, containing 1x N2 supplement, 1x B27 supplement (Minus Vitamin A), 1x NEAA, 1x Glutamax, 10 ng/ml FGF-Basic (AA10-155) Recombinant Human Protein (bFGF, Gibco), 10 ng/ml LIF Recombinant Human Protein (hlif, Gibco), 3 μM CHIR99021 (Selleckchem), 5μM SB431542 (Selleckchem), and 200 μM L-Ascorbic acid 2-phosphate sesquimagnesium salt hydrate (Sigma). .. For neurospheres assays, cells were cultured in DMEM-F12 with 1x B27 supplement, 20 ng/mL Recombinant Human Protein (EGF, Gibco), 20 ng/mL bFGF, and 10 ng/mL hlif using low-attachment culture dishes (Corning).

    Article Title: Flavonoid chrysin activates both TrkB and FGFR1 receptors while upregulates their endogenous ligands such as brain derived neurotrophic factor to promote human neurogenesis
    Article Snippet: .. The human iPSC‐derived NSC cells were maintained as adherent culture in 50% Dulbecco's Modified Eagle Medium (DMEM)‐F12 and 50% neurobasal, containing 1× N2 supplement, 1× B27 supplement (Minus Vitamin A), 1× non‐essential amino acids (NEAA), 1× GlutaMAX, 10 ng/mL FGF‐Basic (AA10‐155) Recombinant Human Protein (basic FGF‐bFGF, Gibco), 10 ng/mL LIF recombinant Human Protein (hlif, Gibco), 3 μM CHIR99021 (Selleckchem), 5 μM SB431542 (Selleckchem) and 200 μM L‐ascorbic acid 2‐phosphate sesquimagnesium salt hydrate (Sigma). ..

    Article Title: Flavonoid chrysin activates both TrkB and FGFR1 receptors while upregulates their endogenous ligands such as brain derived neurotrophic factor to promote human neurogenesis.
    Article Snippet: .. The human iPSC-derived NSC cells were maintained as adherent culture in 50% Dulbecco's Modified Eagle Medium (DMEM)-F12 and 50% neurobasal, containing 1 N2 supplement, 1 B27 supplement (Minus Vitamin A), 1 non-essential amino acids (NEAA), 1 GlutaMAX, 10 ng/mL FGF-Basic (AA10-155) Recombinant Human Protein (basic FGF-bFGF, Gibco), 10 ng/mL LIF recombinant Human Protein (hlif, Gibco), 3 μM CHIR99021 (Selleckchem), 5 μM SB431542 (Selleckchem) and 200 μM L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate (Sigma). ..

    Article Title: β-Arrestin 2 and Epac2 Cooperatively Mediate DRD1-Stimulated Proliferation of Human Neural Stem Cells and Growth of Human Cerebral Organoids.
    Article Snippet: .. The human iPSC-derived NSC cells were maintained as adherent culture in 50% DMEM-F12 and 50% Neurobasal-A, containing 1× N2 supplement, 1× B27 supplement (Minus Vitamin A), 1× NEAA, 1× Glutamax, 10 ng/mL FGF-Basic (AA10-155) Recombinant Human Protein (basic fibroblast growth factor-bFGF, Gibco), 10 ng/mL LIF Recombinant Human Protein (hlif, Gibco), 3 μM CHIR99021 (Selleckchem), 5 μM SB431542 (Selleckchem), and 200 μM L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate (Sigma). .. SKF83566 was purchased from Tocris Bioscience; ESI-05, HJC0350, SB203580, SKF86002, PD98059, SP600125 were purchased from MedChemExpress; Cell CountingLite 2.0 Luminescent cell viability assay was purchased from Vazyme.

    Modification:

    Article Title: Flavonoid chrysin activates both TrkB and FGFR1 receptors while upregulates their endogenous ligands such as brain derived neurotrophic factor to promote human neurogenesis
    Article Snippet: .. The human iPSC‐derived NSC cells were maintained as adherent culture in 50% Dulbecco's Modified Eagle Medium (DMEM)‐F12 and 50% neurobasal, containing 1× N2 supplement, 1× B27 supplement (Minus Vitamin A), 1× non‐essential amino acids (NEAA), 1× GlutaMAX, 10 ng/mL FGF‐Basic (AA10‐155) Recombinant Human Protein (basic FGF‐bFGF, Gibco), 10 ng/mL LIF recombinant Human Protein (hlif, Gibco), 3 μM CHIR99021 (Selleckchem), 5 μM SB431542 (Selleckchem) and 200 μM L‐ascorbic acid 2‐phosphate sesquimagnesium salt hydrate (Sigma). ..

    Article Title: Flavonoid chrysin activates both TrkB and FGFR1 receptors while upregulates their endogenous ligands such as brain derived neurotrophic factor to promote human neurogenesis.
    Article Snippet: .. The human iPSC-derived NSC cells were maintained as adherent culture in 50% Dulbecco's Modified Eagle Medium (DMEM)-F12 and 50% neurobasal, containing 1 N2 supplement, 1 B27 supplement (Minus Vitamin A), 1 non-essential amino acids (NEAA), 1 GlutaMAX, 10 ng/mL FGF-Basic (AA10-155) Recombinant Human Protein (basic FGF-bFGF, Gibco), 10 ng/mL LIF recombinant Human Protein (hlif, Gibco), 3 μM CHIR99021 (Selleckchem), 5 μM SB431542 (Selleckchem) and 200 μM L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate (Sigma). ..



    Similar Products

    94
    Cell Signaling Technology Inc hlif
    Hlif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lif+recombinant+human+protein+(hlif/Human+LIF+Recombinant+Protein/pmc12805378-15-0-2
    Average 94 stars, based on 1 article reviews
    hlif - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    R&D Systems hlif
    Hlif, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lif+recombinant+human+protein+(hlif/Recombinant+Human+LIF+Protein/pmc12683510-39-37-40
    Average 93 stars, based on 1 article reviews
    hlif - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher lif recombinant human protein (hlif
    Lif Recombinant Human Protein (Hlif, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lif+recombinant+human+protein+(hlif/pm35772103-23-44-49
    Average 90 stars, based on 1 article reviews
    lif recombinant human protein (hlif - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    93
    Sino Biological recombinant hlif his
    a Yeast-displayed eLIFR containing the CBM I–Ig-like–CBM II domains (blue circles) has a slightly higher affinity for LIF-His than eLIFR CBM I–Ig-like domains (gray squares). Data are the mean ± SD of triplicate measurements. Data from individual experiments are shown as faint symbols. b Schematic of hLIFR-Fc and eLIFR-Fc. The three N-terminal domains, CBM I–Ig-like–CBM II, are fused to an hIgG1 Fc-domain, with the engineered Ig-like domain shown in dark teal for eLIFR-Fc. c Versus hLIFR-Fc, eLIFR-Fc remains more strongly bound to yeast-displayed LIF after overnight incubation with soluble LIF competitor, indicating a slower off-rate. * P = 0.024, ** P = 0.0024 versus the corresponding hLIFR-Fc condition, two-tailed unpaired Student’s t test. Data are mean ± SD ( n = 3). d KinExA data showing <t>that</t> <t>recombinant</t> eLIFR-Fc (blue triangles) has higher affinity to soluble <t>hLIF-His</t> than hLIFR-Fc (brown circles). Data are the mean of duplicate measurements. Data from individual experiments are shown as faint symbols. e hLIFR-Fc, eLIFR-Fc (bivalent and one-arm), and D25 antibody compete LIF away from WT LIFR. ns not significant, P = 0.03 for one-arm eLIFR-Fc and P = 0.04 for eLIFR-Fc versus hLIFR-Fc, two-tailed unpaired Student’s t test. f Both hLIFR-Fc and eLIFR-Fc (bivalent and one-arm) compete LIF away from WT gp130, but the D25 mAb does not and appears to increase binding, perhaps due to complex stabilization or more avid LIF binding. P = 0.02, ** P = 0.006, or *** P < = 0.0002 versus hLIFR-Fc or eLIFR-Fc (as indicated), two-tailed unpaired Student’s t test. For e and f , data are mean ± SD ( n ≥ 3 independent experiments).
    Recombinant Hlif His, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lif+recombinant+human+protein+(hlif/Human+LIF+Protein/pmc08041770-289-0-3
    Average 93 stars, based on 1 article reviews
    recombinant hlif his - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    Alomone Labs human lif hlif
    a Yeast-displayed eLIFR containing the CBM I–Ig-like–CBM II domains (blue circles) has a slightly higher affinity for LIF-His than eLIFR CBM I–Ig-like domains (gray squares). Data are the mean ± SD of triplicate measurements. Data from individual experiments are shown as faint symbols. b Schematic of hLIFR-Fc and eLIFR-Fc. The three N-terminal domains, CBM I–Ig-like–CBM II, are fused to an hIgG1 Fc-domain, with the engineered Ig-like domain shown in dark teal for eLIFR-Fc. c Versus hLIFR-Fc, eLIFR-Fc remains more strongly bound to yeast-displayed LIF after overnight incubation with soluble LIF competitor, indicating a slower off-rate. * P = 0.024, ** P = 0.0024 versus the corresponding hLIFR-Fc condition, two-tailed unpaired Student’s t test. Data are mean ± SD ( n = 3). d KinExA data showing <t>that</t> <t>recombinant</t> eLIFR-Fc (blue triangles) has higher affinity to soluble <t>hLIF-His</t> than hLIFR-Fc (brown circles). Data are the mean of duplicate measurements. Data from individual experiments are shown as faint symbols. e hLIFR-Fc, eLIFR-Fc (bivalent and one-arm), and D25 antibody compete LIF away from WT LIFR. ns not significant, P = 0.03 for one-arm eLIFR-Fc and P = 0.04 for eLIFR-Fc versus hLIFR-Fc, two-tailed unpaired Student’s t test. f Both hLIFR-Fc and eLIFR-Fc (bivalent and one-arm) compete LIF away from WT gp130, but the D25 mAb does not and appears to increase binding, perhaps due to complex stabilization or more avid LIF binding. P = 0.02, ** P = 0.006, or *** P < = 0.0002 versus hLIFR-Fc or eLIFR-Fc (as indicated), two-tailed unpaired Student’s t test. For e and f , data are mean ± SD ( n ≥ 3 independent experiments).
    Human Lif Hlif, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lif+recombinant+human+protein+(hlif/Recombinant+human+LIF+protein/10__1016_slash_S0306___4522_ascii40_98_ascii41_00405___9-45-11-14
    Average 94 stars, based on 1 article reviews
    human lif hlif - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant hlif
    FIG. 1. Cross-reaction in mLIF and <t>hLIF</t> RIAs. Serial dilutions of a mixture of IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, G-CSF, IFN, and TGF at the highest dose (131 ng/mL; R&D Systems); hOSM at the highest dose 100 ng/mL; and mLIF at the highest dose of 100 ng/mL were applied to the hLIF RIA (top). Serial dilutions of hLIF (highest dose, 100 ng/mL), mIL-6 (highest dose, 100 ng/mL), and hOSM (high- est dose, 100 ng/mL) were applied to the mLIF RIA (bottom).
    Recombinant Hlif, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lif+recombinant+human+protein+(hlif/Recombinant+Human+LIF+Protein/pm09543156-27-8-21
    Average 93 stars, based on 1 article reviews
    recombinant hlif - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    R&D Systems human recombinant leukemia inhibitory factor hlif
    FIG. 1. Cross-reaction in mLIF and <t>hLIF</t> RIAs. Serial dilutions of a mixture of IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, G-CSF, IFN, and TGF at the highest dose (131 ng/mL; R&D Systems); hOSM at the highest dose 100 ng/mL; and mLIF at the highest dose of 100 ng/mL were applied to the hLIF RIA (top). Serial dilutions of hLIF (highest dose, 100 ng/mL), mIL-6 (highest dose, 100 ng/mL), and hOSM (high- est dose, 100 ng/mL) were applied to the mLIF RIA (bottom).
    Human Recombinant Leukemia Inhibitory Factor Hlif, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lif+recombinant+human+protein+(hlif/Recombinant+Human+LIF+Protein/pm08689027-62-46-52
    Average 93 stars, based on 1 article reviews
    human recombinant leukemia inhibitory factor hlif - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    a Yeast-displayed eLIFR containing the CBM I–Ig-like–CBM II domains (blue circles) has a slightly higher affinity for LIF-His than eLIFR CBM I–Ig-like domains (gray squares). Data are the mean ± SD of triplicate measurements. Data from individual experiments are shown as faint symbols. b Schematic of hLIFR-Fc and eLIFR-Fc. The three N-terminal domains, CBM I–Ig-like–CBM II, are fused to an hIgG1 Fc-domain, with the engineered Ig-like domain shown in dark teal for eLIFR-Fc. c Versus hLIFR-Fc, eLIFR-Fc remains more strongly bound to yeast-displayed LIF after overnight incubation with soluble LIF competitor, indicating a slower off-rate. * P = 0.024, ** P = 0.0024 versus the corresponding hLIFR-Fc condition, two-tailed unpaired Student’s t test. Data are mean ± SD ( n = 3). d KinExA data showing that recombinant eLIFR-Fc (blue triangles) has higher affinity to soluble hLIF-His than hLIFR-Fc (brown circles). Data are the mean of duplicate measurements. Data from individual experiments are shown as faint symbols. e hLIFR-Fc, eLIFR-Fc (bivalent and one-arm), and D25 antibody compete LIF away from WT LIFR. ns not significant, P = 0.03 for one-arm eLIFR-Fc and P = 0.04 for eLIFR-Fc versus hLIFR-Fc, two-tailed unpaired Student’s t test. f Both hLIFR-Fc and eLIFR-Fc (bivalent and one-arm) compete LIF away from WT gp130, but the D25 mAb does not and appears to increase binding, perhaps due to complex stabilization or more avid LIF binding. P = 0.02, ** P = 0.006, or *** P < = 0.0002 versus hLIFR-Fc or eLIFR-Fc (as indicated), two-tailed unpaired Student’s t test. For e and f , data are mean ± SD ( n ≥ 3 independent experiments).

    Journal: Communications Biology

    Article Title: An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy

    doi: 10.1038/s42003-021-01928-2

    Figure Lengend Snippet: a Yeast-displayed eLIFR containing the CBM I–Ig-like–CBM II domains (blue circles) has a slightly higher affinity for LIF-His than eLIFR CBM I–Ig-like domains (gray squares). Data are the mean ± SD of triplicate measurements. Data from individual experiments are shown as faint symbols. b Schematic of hLIFR-Fc and eLIFR-Fc. The three N-terminal domains, CBM I–Ig-like–CBM II, are fused to an hIgG1 Fc-domain, with the engineered Ig-like domain shown in dark teal for eLIFR-Fc. c Versus hLIFR-Fc, eLIFR-Fc remains more strongly bound to yeast-displayed LIF after overnight incubation with soluble LIF competitor, indicating a slower off-rate. * P = 0.024, ** P = 0.0024 versus the corresponding hLIFR-Fc condition, two-tailed unpaired Student’s t test. Data are mean ± SD ( n = 3). d KinExA data showing that recombinant eLIFR-Fc (blue triangles) has higher affinity to soluble hLIF-His than hLIFR-Fc (brown circles). Data are the mean of duplicate measurements. Data from individual experiments are shown as faint symbols. e hLIFR-Fc, eLIFR-Fc (bivalent and one-arm), and D25 antibody compete LIF away from WT LIFR. ns not significant, P = 0.03 for one-arm eLIFR-Fc and P = 0.04 for eLIFR-Fc versus hLIFR-Fc, two-tailed unpaired Student’s t test. f Both hLIFR-Fc and eLIFR-Fc (bivalent and one-arm) compete LIF away from WT gp130, but the D25 mAb does not and appears to increase binding, perhaps due to complex stabilization or more avid LIF binding. P = 0.02, ** P = 0.006, or *** P < = 0.0002 versus hLIFR-Fc or eLIFR-Fc (as indicated), two-tailed unpaired Student’s t test. For e and f , data are mean ± SD ( n ≥ 3 independent experiments).

    Article Snippet: Recombinant hLIF-His (14890-H08H-20, Sino Biological Inc.), hLIF (untagged) (14890-HNAH-50, Sino Biological Inc.), mLIF-His (ABIN2215872, Antibodies-Online), hOSM-His (10425-H08H-20, Sino Biological Inc.), and hCTF-1-Fc (16013-H01H-20, Sino Biological Inc.) were purchased for use.

    Techniques: Incubation, Two Tailed Test, Recombinant, Binding Assay

    FIG. 1. Cross-reaction in mLIF and hLIF RIAs. Serial dilutions of a mixture of IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, G-CSF, IFN, and TGF at the highest dose (131 ng/mL; R&D Systems); hOSM at the highest dose 100 ng/mL; and mLIF at the highest dose of 100 ng/mL were applied to the hLIF RIA (top). Serial dilutions of hLIF (highest dose, 100 ng/mL), mIL-6 (highest dose, 100 ng/mL), and hOSM (high- est dose, 100 ng/mL) were applied to the mLIF RIA (bottom).

    Journal: The Journal of clinical endocrinology and metabolism

    Article Title: Measurement of leukemia inhibitory factor in biological fluids by radioimmunoassay.

    doi: 10.1210/jcem.83.4.4702

    Figure Lengend Snippet: FIG. 1. Cross-reaction in mLIF and hLIF RIAs. Serial dilutions of a mixture of IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, G-CSF, IFN, and TGF at the highest dose (131 ng/mL; R&D Systems); hOSM at the highest dose 100 ng/mL; and mLIF at the highest dose of 100 ng/mL were applied to the hLIF RIA (top). Serial dilutions of hLIF (highest dose, 100 ng/mL), mIL-6 (highest dose, 100 ng/mL), and hOSM (high- est dose, 100 ng/mL) were applied to the mLIF RIA (bottom).

    Article Snippet: Materials and Methods Radioiodination of LIF Escherichia coli-derived recombinant hLIF, mLIF, goat polyclonal antihLIF antibody, and anti-mLIF antibody were commercially purchased (R&D Systems, Minneapolis, MN).

    Techniques:

    FIG. 2. Size-exclusion profile of [125I]LIF in serum. The Ultrogel AcA 22 (1.5 3 95-cm) column was equilibrated and run in 0.01 mol/L PBS at 1.5 mL/fraction. Fraction number: void volume, 33; total volume, 105; and 31 kDa, 72. A, [125I]hLIF in the presence or absence of human nonpregnant serum. B, [125I]hLIF in human pregnancy serum with or without a 40-fold excess of unlabeled hLIF. C, [125I]mLIF incubated in pregnant mouse serum.

    Journal: The Journal of clinical endocrinology and metabolism

    Article Title: Measurement of leukemia inhibitory factor in biological fluids by radioimmunoassay.

    doi: 10.1210/jcem.83.4.4702

    Figure Lengend Snippet: FIG. 2. Size-exclusion profile of [125I]LIF in serum. The Ultrogel AcA 22 (1.5 3 95-cm) column was equilibrated and run in 0.01 mol/L PBS at 1.5 mL/fraction. Fraction number: void volume, 33; total volume, 105; and 31 kDa, 72. A, [125I]hLIF in the presence or absence of human nonpregnant serum. B, [125I]hLIF in human pregnancy serum with or without a 40-fold excess of unlabeled hLIF. C, [125I]mLIF incubated in pregnant mouse serum.

    Article Snippet: Materials and Methods Radioiodination of LIF Escherichia coli-derived recombinant hLIF, mLIF, goat polyclonal antihLIF antibody, and anti-mLIF antibody were commercially purchased (R&D Systems, Minneapolis, MN).

    Techniques: Incubation